DSMB will receive blinded data from the Trial Data Center. The DSMB will evaluate events such as death, causes of death, recurrent stroke, MI, and adverse effects. The DSMB may advise early interruption of the trial if analyses demonstrate significant difference in the occurrence of secondary outcome measures with p < 0.001 between group A and group B.